Letrozole and palbociclib in advanced breast cancer: Outcome from cancer institute, Chennai by Vijay Gnanaguru, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Archit Joshi, Arun Kumar Rajan, Gangothri Selvarajan, Parathan Karunakaran, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Madhu Priya, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Krishna Kumar, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar

Subjects: Get full text

A versatile drug delivery system targeting senescent cells by Daniel Muñoz‐Espín, Miguel Rovira, Irene Galiana, Cristina Giménez, Beatriz Lozano‐Torres, Marta Paez‐Ribes, Susana Llanos, Selim Chaib, Maribel Muñoz‐Martín, Alvaro C Ucero, Guillermo Garaulet, Francisca Mulero, Stephen G Dann, Todd VanArsdale, David J Shields, Andrea Bernardos, José Ramón Murguía, Ramón Martínez‐Máñez, Manuel Serrano

Subjects: Get full text

Surgical resection due to poor outcome of the immunotherapy of a relapsed mediastinal liposarcoma: a case report by Ming-Ji Wang, Shu-Quan Xu, Lei-Lei Wu, Zhi-Xin Li, Dong Xie

Subjects: Get full text

PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT by E. V. Artamonova

Subjects: Get full text

CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia by Talveen S Purba, Kayumba Ng'andu, Lars Brunken, Eleanor Smart, Ellen Mitchell, Nashat Hassan, Aaron O'Brien, Charlotte Mellor, Jennifer Jackson, Asim Shahmalak, Ralf Paus

Subjects: Get full text

Palbociclib as an Antitumor Drug: A License to Kill by Agnieszka Łupicka-Słowik, Federica Cossu, Marcin Sieńczyk

Subjects: “…palbociclib…”
Get full text

Enhancing palbociclib efficacy with low toxicity in breast cancer using polycaprolactone-based nanocarriers by Nastaran Zerang, Zohreh Mirjafary, Hamid Saeidian, Morteza Rouhani

Subjects: “…Palbociclib…”
Get full text

Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross... by Benlong Yang, Zhengkui Sun, Quchang Ouyang, Zhongsheng Tong, Shu Wang, Hongyuan Li, Zhaofeng Niu, Yiding Chen, Lin-xiaoxi Ma, Haoqi Wang, Mu Tang, Zheyu Hu, Xueqiang Gao, Xu Wang, Fei Xie, Qiao Cheng, Yong Shen, Cuizhi Geng, Haibo Wang, Jiong Wu

Subjects: Get full text

Surface functionalized albumin nanoparticles of palbociclib with amplified brain delivery for treating brain glioblastoma by Vishwanath Kurawattimath, Barnabas Wilson, Kannoth Mukundan Geetha, Kalpana Divekar

Subjects: Get full text

Cisplatin palbociclib combination differentially modulates PTEN AKT signaling via Hsp90 in hepatocellular carcinoma cells by Hameis M. Sleem, Aya A. Ali, Eman Ramadan

Subjects: Get full text

The deleterious effects of CDK4/6 inhibition on renal recovery post-acute kidney injury by Shanshan Zhou, Rouzhang Peng, Yanting Shen, Liuwei Huang, Suying Han, Jun Wang, Jie Guo

Subjects: Get full text

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY by E. V. Artamonova

Subjects: Get full text

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume by Bediz Kurt İnci, Pınar Kubilay Tolunay, Şura Öztekin, Ergin Aydemir, İrem Öner, Öztürk Ateş, Cengiz Karaçin

Subjects: Get full text

Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities by Mashael Algethami, Ahmed Shoqafi, Ayat Lashen, Shatha Alqahtani, Jake Spicer, Ahmad ALtayyar, Çağla Tosun, Jennie N Jeyapalan, Nigel P. Mongan, Victoria James, Emad A. Rakha, Srinivasan Madhusudan

Subjects: Get full text

Modeling the impact of CDK4 / 6 inhibitors on reducing cancer mortality by N. A. Avxentyev, E. V. Bilan, A. Yu. Goryainova, Yu. V. Makarova, R. A. Murashko, A. V. Sobolev, S. V. Sharov, D. Yu. Yukalchuk

Subjects: Get full text

CD4+ lymphocytopenia and Pneumocystis jirovecii pneumonia in a metastatic breast cancer patient treated with palbociclib and corticosteroids by Shahar Dekel, Emmanuelle Alaluf, Tal Sella, Avshalom Leibowitz, Ana Belkin

Subjects: “…palbociclib…”
Get full text

Population Pharmacokinetic and Pharmacodynamic Study of Palbociclib in Children and Young Adults with Recurrent, Progressive, or Refractory Brain Tumors by John C. Panetta, Nicholas S. Selvo, David Van Mater, Clinton F. Stewart

Subjects: “…palbociclib…”
Get full text

Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors by Zehra Sucuoğlu İşleyen, Harun Muğlu, Zeynep Alaca Topçu, Mehmet Beşiroğlu, Ayşe İrem Yasin, Atakan Topçu, Melih Şimşek, Mesut Şeker, Hacı Mehmet Türk

Subjects: Get full text

A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer by Jialin Zhang, Xinyu Xu, Yeyue Zhou, Jingyang Su, Jue Wang

Subjects: Get full text

Clinical Prognosis and Nomograms for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Patients Treated with Palbociclib and... by Song S, Sun L, Liu X, Zhang L, Li C, Liu Z, Liu F, Yu Z

Subjects: Get full text